Search results

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.

Macromolecular crystallography beamline team at the Australian Synchrotron.

The National Deuteration Facility offers the facilities and expertise to produce molecules where all or part of the molecular hydrogen is replaced with deuterium. This enables complex investigations of the relationship between the structure of molecules and their function using neutron scattering and other techniques.

Discover the many career opportunities in the nuclear industry on a special behind the scenes tour of ANSTO.